Table 2.
Total | First Vaccine Dose | Second Vaccine Dose | |
---|---|---|---|
Study population | 310 | 310 | 288 |
All AEFIs, n | 913 | 539 | 374 |
Short-term AEFIs, n (%) | 790 (86.5) | 438 (81.3) | 352 (94.1) |
Long-term AEFIs, n (%) | 123 (13.5) | 101 (18.7) | 22 (5.9) |
Total | First Vaccine Dose | Second Vaccine Dose | |
---|---|---|---|
Study population | 310 | 310 | 288 |
All AEFIs, n | 913 | 539 | 374 |
Short-term AEFIs, n (%) | 790 (86.5) | 438 (81.3) | 352 (94.1) |
Long-term AEFIs, n (%) | 123 (13.5) | 101 (18.7) | 22 (5.9) |